Abstract Details
|
Activity Number:
|
69
|
|
Type:
|
Topic Contributed
|
|
Date/Time:
|
Sunday, August 4, 2013 : 4:00 PM to 5:50 PM
|
|
Sponsor:
|
Biopharmaceutical Section
|
| Abstract - #307757 |
|
Title:
|
Statistical Assessment of Comparative Efficacy in Adolescent Psychiatry Clinical Trials
|
|
Author(s):
|
Isaac Nuamah*+
|
|
Companies:
|
Janssen Research and Development
|
|
Keywords:
|
systematic reviews ;
meta-analysis ;
comparative effectiveness ;
schizophrenia ;
adolescents
|
|
Abstract:
|
New generation atypical antipsychotics are used to treat adolescent psychiatric disorders such as schizophrenia. However, only a few have been approved by US FDA for pediatric indication. In this work we carried out a systematic review of randomized-controlled studies conducted to evaluate the effectiveness of APs in adolescents (12-18 years suffering from schizophrenia. By use of meta-analysis, we show the comparative efficacy of APs in controlling psychotic symptoms with adolescent with schizophrenia.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2013 program
|
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.